Alnylam Pharmaceuticals Inc (DUL)
Market Closed
17 Jul, 20:00
€
233. 20
-14.2
-5.7397%
€
- Market Cap
- P/E Ratio
- Div Yield
10 Volume
-3.56 Eps
€ 247.4
Previous Close Want to track DUL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | 1.59 | - |
| | | 1.5 | - |
| | | 1.75 | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
DUL Earnings Reports FAQ
What is the earnings per share (EPS) for DUL?
The current EPS is -3.56.
What is the company's earnings growth rate?
Alnylam Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Alnylam Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Alnylam Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for DUL at this time, as Alnylam Pharmaceuticals Inc has no recent EPS data to calculate it.
